Cargando…

A211 CAN AN EXPERIMENTAL MOUSE MODEL BE USED TO CHARACTERIZE BEHAVIOURAL COMORBIDITIES ASSOCIATED WITH INFLAMMATORY BOWEL DISEASES?

BACKGROUND: Inflammatory Bowel Diseases (IBD) are increasing globally with westernized countries experiencing a dramatic increase in cases of ulcerative colitis and Crohn’s disease. The corresponding rise in the comorbidities of anxiety and depression are linked to inflammation and microbiome dysbio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Josephson, J, Barnett, J, Chiang, H, Gibson, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991239/ http://dx.doi.org/10.1093/jcag/gwac036.211

Ejemplares similares

A55 YOU ARE WHAT YOUR GREAT, GREAT GRANDPARENTS PARENTS ATE: PRE-NATAL GLYPHOSATE EXPOSURE INDUCES DYSBIOSIS, METABOLIC DYSFUNCTION AND BEHAVIOURAL ABNORMALITIES THREE GENERATIONS AFTER EXPOSURE
por: Barnett, J A, et al.
Publicado: (2023)

Inflammatory arthritis associated with inflammatory bowel disease in children
por: Desgranges, M, et al.
Publicado: (2008)

P211: Organization and scope of infection control in Polish hospitals. First results of the pan-european prohibit survey
por: Różańska, A, et al.
Publicado: (2013)

Genetic polymorphisms of inflammatory molecules in Tunisian inflammatory bowel diseases
por: Gorgi, Y, et al.
Publicado: (2010)

A214 WOMEN WITH INFLAMMATORY BOWEL DISEASE HAVE INCREASED HEALTH-CARE UTILIZATION DURING PREGNANCY AND POSTPARTUM COMPARED TO THOSE WITHOUT INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED COHORT STUDY
por: Tandon, P, et al.
Publicado: (2023)

Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome
por: Aronson, Melyssa, et al.
Publicado: (2010)

Towards cardiac and respiratory motion characterization from electrophysiology data for improved real time MR-integration
por: Roujol, Sébastien, et al.
Publicado: (2013)

A166 RISK STRATIFICATION OF EARLY RE-HOSPITALIZATION IN PERSONS WITH INFLAMMATORY BOWEL DISEASES USING MULTIVARIABLE MODELS
por: Dziegielewski, C, et al.
Publicado: (2023)

A84 FACTORS ASSOCIATED WITH HIGH LEVELS OF TELEPHONE CARE SATISFACTION AMONG INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Foncham, J N, et al.
Publicado: (2023)

P02.120. Qualitative systemic review on Complementary and Alternative Medicine treatments in Inflammatory Bowel Diseases
por: Langhorst, J, et al.
Publicado: (2012)

P008 A systematic review and meta-analysis of inflammatory bowel disease activity and sleep quality
por: Barnes, A, et al.
Publicado: (2021)

A159 RISK OF TOTAL METACHRONOUS ADVANCED NEOPLASIA IN PATIENTS WITH SERRATED LESIONS AND INFLAMMATORY BOWEL DISEASE
por: Medawar, E, et al.
Publicado: (2023)

A225 QUANTIFICATION OF BONE DENSITY AND DIETARY RISK FACTORS FOR BONE FRAGILITY IN INFLAMMATORY BOWEL DISEASE
por: Macci, A, et al.
Publicado: (2023)

The Effect of Cumulative Dose of Glucocorticoids on Bone in Children with Inflammatory Bowel Disease (3-year Follow- up study)
por: Tomková, S, et al.
Publicado: (2013)

Clinical and genetic analyses in a patient with PAPA syndrome complicated with inflammatory bowel disease
por: Ida, H, et al.
Publicado: (2015)

A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Markovinovic, A, et al.
Publicado: (2023)

A199 BIOFILMS IN THE APPENDIX AND OTHER NON-INFLAMED SECTIONS OF THE COLON IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Arjomand Fard, N, et al.
Publicado: (2023)

A87 PERSPECTIVES ON DIET MODIFICATION TO MANAGE THEIR SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. A SCOPING REVIEW
por: Noejovich, C V, et al.
Publicado: (2023)

A101 VIRTUAL MINDFULNESS-BASED STRESS REDUCTION FOR ADULTS WITH INFLAMMATORY BOWEL DISEASE: FEASIBILITY TRIAL PRELIMINARY RESULTS
por: Chappell, K, et al.
Publicado: (2023)

A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS
por: Coward, S, et al.
Publicado: (2023)

Phenotypic characterization of mouse mammary epithelial stem and progenitor cells
por: Stingl, J, et al.
Publicado: (2006)

A202 INVESTIGATION OF THE DIRECT EFFECT OF HEMIN-HEMOPEXIN AND HAPTOGLOBIN STIMULATION IN INFLAMMATORY BOWEL DISEASE
por: Ajayi, A S, et al.
Publicado: (2023)

The comorbidity between migraine and hypothyroidism
por: Lisotto, C, et al.
Publicado: (2013)

A177 RISK OF VENOUS THROMBOEMBOLISM IN COVID-19 PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED MATCHED COHORT STUDY
por: Khan, R, et al.
Publicado: (2023)

Characterization of tumor infiltrated cells in mouse model
por: Liou, Yae-Huei, et al.
Publicado: (2015)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

A197 INVESTIGATING THE PROTON-PUMP INHIBITOR USE PRECEDING AND POST AN INFLAMMATORY BOWEL DISEASE DIAGNOSIS
por: Singh, N, et al.
Publicado: (2023)

A168 COSTS OF MISSED WORK AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A CROSS-SECTIONAL POPULATION-REPRESENTATIVE STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

Psychiatric comorbidity in patients of Irritable Bowel Syndrome
por: Chhiber, Sonakshi
Publicado: (2022)

Comorbidity with depression and overweight in children with asthma
por: Bahreinian, Salma, et al.
Publicado: (2010)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE
por: Iablokov, V, et al.
Publicado: (2023)

A252 LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: KINGSTON HEALTH SCIENCES CENTER LOCAL EXPERIENCE
por: Greenblatt, M, et al.
Publicado: (2023)

A90 IMPLEMENTATION OF NATIONAL GUIDELINES ON THE MANAGEMENT OF VACCINE PREVENTABLE ILLNESS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PERCEIVED BARRIERS AND INTERVENTION FUNCTIONS AMONGST GASTROENTEROLOGISTS
por: Zhou, F, et al.
Publicado: (2023)

A182 PREDICTING HIGH DIRECT HEALTHCARE COSTS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE FIRST YEAR FOLLOWING DIAGNOSIS
por: Kuenzig, E, et al.
Publicado: (2023)

A94 EXPLORING THE SOCIOECONOMIC BURDEN OF PEDIATRIC INFLAMMATORY BOWEL DISEASE: A SURVEY OF FAMILIES AND PEDIATRIC PROVIDERS
por: Desai, T, et al.
Publicado: (2023)

Etiology, comorbidity and prognosis of hospitalized patients with congestive heart failure
por: Zhao, Y, et al.
Publicado: (2010)

A217 A REVIEW OF MOBILE HEALTH APPLICATIONS FOR INDIVIDUALS LIVING WITH INFLAMMATORY BOWEL DISEASE USING MOBILE APPLICATION RATING SCALE (MARS)
por: Jannati, N, et al.
Publicado: (2023)

A91 INTERACTIONS BETWEEN PREGNANCY, DELIVERY, AND ILEAL POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE CHART REVIEW
por: House, S C, et al.
Publicado: (2023)

Resistance to morphine analgesia and its underlying mechanisms in an experimental mouse model of fibromyalgia
por: Uchida, Hitoshi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uplslsos0jeu4l2man8k86aqhk